Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 20, 2015 - Issue 4
Submit an article Journal homepage
2,097
Views
22
CrossRef citations to date
0
Altmetric
Editorial

Emerging drugs for preeclampsia – the endothelium as a target

Jennifer M SasserUniversity of Mississippi Medical Center, Department of Pharmacology and Toxicology, 2500 North State Street, Jackson, MS 39216, USA+1 601 984 1629; +1 601 984 1637; [email protected]
, PhD,
Sydney R MurphyUniversity of Mississippi Medical Center, Department of Pharmacology and Toxicology, 2500 North State Street, Jackson, MS 39216, USA+1 601 984 1629; +1 601 984 1637; [email protected]
&
Joey P GrangerUniversity of Mississippi Medical Center, Department of Physiology and Biophysics, 2500 North State Street, Jackson, MS 39216, USA
Pages 527-530 | Published online: 03 Jul 2015

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Esmee C. M. Kooijmans, Helena J. H. van der Pal, Maxime C. F. Pilon, Saskia M. F. Pluijm, Margriet van der Heiden-van der Loo, Leontien C. M. Kremer, Dorine Bresters, Eline van Dulmen-den Broeder, Marry M. van den Heuvel-Eibrink, Jacqueline J. Loonen, Marloes Louwerens, Sebastian J. C. Neggers, Hanneke M. van Santen, Wim J. E. Tissing, Andrica C. H. de Vries, Gertjan J. L. Kaspers, Margreet A. Veening & Arend Bökenkamp. (2022) Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy. Scandinavian Journal of Clinical and Laboratory Investigation 82:7-8, pages 541-548.
Read now
Araceli Jarquin Campos, Lorenz Risch, Marc Baumann, Mette-Triin Purde, Sebastian Neuber, Harald Renz, Beatrice Mosimann, Luigi Raio, Markus Mohaupt, Daniel Surbek & Martin Risch. (2019) Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester. Scandinavian Journal of Clinical and Laboratory Investigation 79:1-2, pages 91-98.
Read now

Articles from other publishers (20)

Marcelo R. Luizon, Daniela A. Pereira, Izabela Mamede, Carla S. Ceron, Ricardo C. Cavalli, Ana C. Palei & Valeria C. Sandrim. (2023) Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications. Frontiers in Pharmacology 14.
Crossref
Xiaobo Liu, Jiajia Li, Wenjun Wang, Xue Ren & Ji-Fan Hu. (2023) Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells. Life Sciences 322, pages 121658.
Crossref
Hannah R. Turbeville & Jennifer M. Sasser. (2020) Preeclampsia beyond pregnancy: long-term consequences for mother and child. American Journal of Physiology-Renal Physiology 318:6, pages F1315-F1326.
Crossref
Laura E. Coats, Gwendolyn K. Davis, Ashley D. Newsome, Norma B. Ojeda & Barbara T. Alexander. (2019) Low Birth Weight, Blood Pressure and Renal Susceptibility. Current Hypertension Reports 21:8.
Crossref
Hannah R. TurbevilleErin B. TaylorMichael R. GarrettSean P. DidionMichael J. RyanJennifer M. Sasser. (2019) Superimposed Preeclampsia Exacerbates Postpartum Renal Injury Despite Lack of Long-Term Blood Pressure Difference in the Dahl Salt-Sensitive Rat. Hypertension 73:3, pages 650-658.
Crossref
Asmaa A. ElMonier, Noha A. El-Boghdady, Mohamed A. Abdelaziz & Amira A. Shaheen. (2019) Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women. Archives of Biochemistry and Biophysics 662, pages 7-14.
Crossref
Marcelo R Luizon, Daniela A Pereira & Jose E Tanus-Santos. (2018) Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics 19:18, pages 1423-1435.
Crossref
Anne Brandolt Larré, Fernando Sontag, Débora Montenegro Pasin, Nathália Paludo, Rayssa Ruszkowski do Amaral, Bartira Ercília Pinheiro da Costa & Carlos Eduardo Poli-de-Figueiredo. (2018) Phosphodiesterase Inhibition in the Treatment of Preeclampsia: What Is New?. Current Hypertension Reports 20:10.
Crossref
Patricia M. Witcher. (2018) Preeclampsia: Acute Complications and Management Priorities. AACN Advanced Critical Care 29:3, pages 316-326.
Crossref
Enrique Esteve-Valverde, Raquel Ferrer-Oliveras, Natàlia Gil-Aliberas, Antònia Baraldès-Farré, Elisa Llurba & Jaume Alijotas-Reig. (2018) Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review. Obstetrical & Gynecological Survey 73:1, pages 40-55.
Crossref
Styliani Goulopoulou. (2017) Maternal Vascular Physiology in Preeclampsia. Hypertension 70:6, pages 1066-1073.
Crossref
M R Luizon, A C T Palei, V A Belo, L M Amaral, R Lacchini, G Duarte, R C Cavalli, V C Sandrim & J E Tanus-Santos. (2016) Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal 17:5, pages 427-434.
Crossref
Anne Brandolt Larré, Aline Parisotto, Bruna Fagundes Rockenbach, Débora Montenegro Pasin, Cláudia Capellari, Daniele Cristovão Escouto, Bartira Ercília Pinheiro da Costa & Carlos Eduardo Poli-de-Figueiredo. (2017) Phosphodiesterases and preeclampsia. Medical Hypotheses 108, pages 94-100.
Crossref
Jaume Alijotas-Reig, Enrique Esteve-Valverde, Raquel Ferrer-Oliveras, Elisa Llurba & Josep Maria Gris. (2017) Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clinical Reviews in Allergy & Immunology 53:1, pages 40-53.
Crossref
Nerolen Soobryan, Saravanakumar Murugesan, Wendy Phoswa, Prem Gathiram, Jagidesa Moodley & Irene Mackraj. (2017) The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia. European Journal of Pharmacology 795, pages 101-107.
Crossref
Crystal A. WestJennifer M. Sasser & Chris Baylis. (2016) The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system. American Journal of Physiology-Renal Physiology 311:6, pages F1125-F1134.
Crossref
Kirk P. Conrad. (2016) G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention. Human Reproduction Update 22:5, pages 647-664.
Crossref
Anton H. van den MeirackerA.H. Jan Danser. (2016) Mechanisms of Hypertension and Renal Injury During Vascular Endothelial Growth Factor Signaling Inhibition. Hypertension 68:1, pages 17-23.
Crossref
S. Ananth Karumanchi. (2016) Angiogenic Factors in Preeclampsia. Hypertension 67:6, pages 1072-1079.
Crossref
Radko Komers & Horacio Plotkin. (2016) Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 310:10, pages R877-R884.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.